Skip to main content
Clinical Trials/CTRI/2023/05/052340
CTRI/2023/05/052340
Not yet recruiting
Phase 2

A RANDOMISED COMPARATIVE CLINICAL STUDY TO EVALUATE THE EFFICACY OF â??PHALTRIKADI YOGAâ??AND â??ERANDA KSHAR YOGAâ?? IN THE MANAGEMENT OF MEDOROGA W.S.R. TO DYSLIPIDEMIA

Ayurvedic and Unani Tibia College Hospital0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Ayurvedic and Unani Tibia College Hospital
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Ayurvedic and Unani Tibia College Hospital

Eligibility Criteria

Inclusion Criteria

  • a) Patients between the age group of 18\-60 years of either sex.
  • b) Willing and able to participate in the study for 90 days.
  • c) Patients having Serum Cholesterol 201\-400mg/dl, Serum Triglycerides 151\- 400 mg/dI LDL Cholesterol 131\-250 mg/dl, HDL
  • Details Cholesterol \<40mg/dI.
  • d)Patients with strictly controlled Diabetes Mellitus (HbA1c less than or equal to 7%)

Exclusion Criteria

  • 1\) Patients who have a past history of Atrial Fibrillation, Acute Coronary Syndrome, Myocardial Infarction, congestive heart failure ,Stroke or severe Arrhythmia, Unstable angina in the last six months.
  • 2\) Patients on prolonged ( \>6weeks) medication with corticosteroids, antidepressants, anti cholinergics, immunosuppressant
  • 3\) Patients with poorly controlled hypertension (systolic \>140 and diastolic \>90 mm of Hg) despite of antihypertensive agents.
  • 4\)Patients with uncontrolled diabetes mellitus and HbA1C \>7%
  • 5\) Patients with evidence of malignancy.
  • 6\)Hypersensitivity to any of the trial drugs or their ingredients.
  • 7\)Patients who have completed participation in any other clinical trial drugs or their ingredients in one month
  • 8\)Patients who have received any cholesterol lowering
  • medication (allopathic drug) within last two weeks.
  • 9\)Pregnancy and Lactating mother.

Outcomes

Primary Outcomes

Not specified

Similar Trials